Examples of using Parallel group in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Based on a parallel group comparison.
The efficacy of tocilizumab for the treatment of active sJIA was assessed in a 12 week randomised, double blind,placebo-controlled, parallel group, two arm study.
A randomised, parallel group, open-label pharmacokinetic study of Cinryze was performed in subjects with non-symptomatic HAE.
The Phase 3 study was a randomised, double-blind,placebo-controlled, parallel group study that included 789 patients.
Two randomized, parallel group, double-blind studies were performed in patients previously treated with anticagulation therapy.
The second paediatric trial was a multicenter, double-blind, double-dummy,randomised, parallel group, active control, single-dose non-inferiority study, comparing i.v. palonosetron 1 µg/kg, max.
In a parallel group study designed to assess the efficacy and safety of riluzole in patients at a late stage of the disease, survival time and motor function under riluzole did not differ significantly from that of placebo.
In another multicentre, randomised, double-blind,active-controlled, parallel group study, a total of 947 patients with mild to severe hypertension who were not adequately controlled on amlodipine.
All parallel groups of fry derived from parents selected based on gene markers associated with IPN and PD resistance(grey line), showing significant reduction in mortality compared to standard fry groups without QTL.
Table 3: Results of study GF 8407 randomised parallel group study comparing efficacy and safety of follitropin alfa with urinary FSH in ART.
A randomised study assessed the clinical efficacy response rate in DMARD-naïve patients(n 121) with early RA, who received either 20 mg or100 mg of leflunomide in two parallel groups during the initial three day double blind period.
Table: Results of study GF 8407 randomised parallel group study comparing efficacy and safety of GONAL-f with urinary FSH in assisted reproduction technologies.
The effectiveness of pitolisant up to 36 mg once a day, for the treatment of narcolepsy with or without cataplexy was established in two main, 8 weeks, multicenter,randomized, double-blind, placebo-controlled, parallel group trials(Harmony I and Harmony CTP).
A 12 week(double-masked,randomized, parallel group) clinical study compared the efficacy and safety of LUMIGAN 0.3 mg/mL single-dose with LUMIGAN 0.3 mg/mL multi-dose formulation.
The safety of Kentera was evaluated in patients with urge urinary incontinence in a randomised, double-blind,placebo-controlled, parallel group Phase 3 study that included 789 patients with 389 patients receiving Kentera and 400 patients receiving placebo.
A 12-week(double-masked, randomized, parallel group) clinical study compared the efficacy and safety of GANFORT single-dose with GANFORT(multi-dose formulation) in patients with glaucoma or ocular hypertension.
In a polysomnographic(PSG) study with a run-in of 2 weeks(single-blind with placebo treatment), followed by a treatment period of 3 weeks(double-blind,placebo-controlled, parallel group design) and a 3-week withdrawal period, sleep latency(SL) was shortened by 9 minutes compared to placebo.
Two controlled, multicentre, randomised, double blind parallel group, Phase III studies provided the data for Panretin gel in the treatment of index cutaneous lesions of KS Table 3.
In 2 large randomized, parallel group, double-blind, dose-confirmatory trials, patients undergoing elective major orthopaedic surgery(one for knee replacement surgery and one for hip replacement surgery) received Pradaxa 75 mg or 110 mg within 1-4 hours of surgery followed by 150 mg or 220 mg daily thereafter, haemostasis having been secured, or enoxaparin 40 mg on the day prior to surgery and daily thereafter.
The potential for Eurartesim to prolong the QTc interval was investigated in parallel groups of healthy volunteers who took each dose with high(~1000 Kcal) or low(~400 Kcal) fat/calorie meals or in fasting conditions.
SMART was a multi-centre, randomised, double blind,placebo-controlled, parallel group 28-week study in the US which randomised 13,176 patients to salmeterol(50 micrograms twice daily) and 13,179 patients to placebo in addition to the patients' usual asthma therapy.
The clinical efficacy and safety of Aerinaze tablets was evaluated in two, 2-week multicentre,randomized parallel group clinical trials involving 1,248 patients 12 to 78 years of age with seasonal allergic rhinitis, 414 of whom received Aerinaze tablets.
In an 8-week multicenter, randomised, double-blind,placebo-controlled, parallel group factorial study in 1461 patients with mild to severe hypertension(mean seated diastolic blood pressure≥95 and≤119 mmHg), treatment with each combination dose of Onduarp resulted in significantly greater diastolic and systolic blood pressure reductions and higher control rates compared to the respective monotherapy components.
The efficacy and safety of Vidaza was studied in an international, multicentre, controlled,open-label, parallel group Phase 3 study in patients 65 years and older with newly diagnosed de novo or secondary AML with> 30% bone marrow blasts according to the WHO classification, who were not eligible for HSCT.
Pharmacokinetics of toremifene were investigated in an open study with four parallel groups of ten subjects: normal subjects, patients with impaired(mean AST 57 U/L- mean ALT 76 U/L- mean gamma GT 329 U/L) or activated liver function(mean AST 25 U/L- mean ALT 30 U/L- mean gamma GT 91 U/L- patients treated with antiepileptics) and patients with impaired renal function creatinine: 176 µmol/L.
In a second outpatient study with two week run in baseline period with placebo and a randomised, double blind,placebo controlled, parallel group treatment period of 3 weeks, the rate of patients who showed a clinically significant improvement in both quality of sleep and morning alertness was 26% in the Circadin group as compared to 15% in the placebo group. .
In a further multicentre, randomised, double-blind,active-controlled, parallel group study, a total of 1097 patients with mild to severe hypertension who were not adequately controlled on amlodipine 5 mg received Onduarp(40 mg/5 mg or 80 mg/5 mg) or amlodipine alone(5 mg or 10 mg).
In an outpatient study with 2 week run-in baseline period with placebo, a randomised, double blind,placebo controlled, parallel group treatment period of 3 weeks and 2 week withdrawal period with placebo, the rate of patients who showed a clinically significant improvement in both quality of sleep and morning alertness was 47% in the Circadin group as compared to 27% in the placebo group. .
In an 8-week multicenter, randomised, double-blind,placebo-controlled, parallel group factorial study in 1461 patients with mild to severe hypertension(mean seated diastolic blood pressure≥95 and≤119 mmHg), treatment with each combination dose of Onduarp resulted in significantly greater diastolic and systolic blood pressure reductions and higher control rates compared to the respective monotherapy components.